Valuation: Balchem Corporation

Market Cap 5.64B 5.04B 4.65B 4.22B 7.89B 536B 8.02B 56.01B 22.18B 281B 21.18B 20.73B 885B P/E 2026 *
32.8x
P/E 2027 * 31.4x
Enterprise Value 5.68B 5.07B 4.68B 4.24B 7.94B 539B 8.07B 56.37B 22.32B 282B 21.31B 20.86B 890B EV / Sales 2026 *
5.02x
EV / Sales 2027 * 4.69x
Free-Float
99.51%
Yield 2026 *
0.66%
Yield 2027 * 0.74%
1 day+2.18%
1 week+3.67%
Current month+7.30%
1 month+5.21%
3 months+9.94%
6 months+0.27%
Current year+15.41%
1 week 169.72
Extreme 169.7152
177.45
1 month 161.05
Extreme 161.0501
177.45
Current year 152.58
Extreme 152.58
183.9
1 year 147.18
Extreme 147.18
183.9
3 years 110.74
Extreme 110.74
186.03
5 years 110.15
Extreme 110.1456
186.03
10 years 67.71
Extreme 67.71
186.03
Manager TitleAgeSince
Chief Executive Officer 61 2015-04-27
Director of Finance/CFO 49 2019-02-03
Chief Tech/Sci/R&D Officer 56 2025-09-30
Director TitleAgeSince
Director/Board Member 63 2010-09-15
Chairman 61 2016-12-31
Director/Board Member 59 2015-09-14
Date Insider Type Main position Quantity % Market Cap. Importance
4/1/26 Other

Controller/Auditor

8,646 0.0270%
2/11/26 Free

Director

870 0.0027%
2/11/26 Free

Director

870 0.0027%
Change 5-day change 1-year change 3-year change Capi.($)
+2.18%+3.67%+12.90%+45.21% 5.64B
-1.29%-0.12%+4.91%+81.29% 80.88B
+0.45%+1.99%+12.67%+40.50% 44.68B
-2.33%-1.29%+1.84%-16.54% 35.05B
-0.13%-0.40%+9.15%+17.57% 33.8B
+0.52%+5.87%+18.01%+72.52% 33.61B
-0.38%-1.22%-4.29%+21.40% 25.85B
-0.85%-0.96%+52.88%+45.64% 24.84B
+1.07%+4.68%-44.01%-37.03% 18.44B
+1.37%-5.08%+28.35%+13.13% 16.32B
Average +0.06%+0.54%+9.24%+28.37% 31.91B
Weighted average by Cap. -0.41%+0.50%+8.99%+38.58%

Financials

2026 *2027 *
Net sales 1.13B 1.01B 934M 846M 1.58B 107B 1.61B 11.23B 4.45B 56.28B 4.25B 4.16B 177B 1.2B 1.07B 986M 894M 1.67B 114B 1.7B 11.87B 4.7B 59.47B 4.49B 4.39B 188B
Net income 175M 156M 144M 131M 245M 16.6B 249M 1.74B 687M 8.7B 656M 642M 27.42B 182M 163M 150M 136M 255M 17.3B 259M 1.81B 716M 9.06B 684M 669M 28.57B
Net Debt 35.51M 31.71M 29.3M 26.55M 49.67M 3.37B 50.49M 353M 140M 1.77B 133M 130M 5.57B -39.68M -35.43M -32.73M -29.66M -55.5M -3.77B -56.41M -394M -156M -1.97B -149M -146M -6.22B
Projected Income Statement - Annual - Balchem Corporation
Logo Balchem Corporation
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Employees
1,379
Date Price Change Volume
26-10-23 US$177.00 +2.18% 717,785
26-10-22 US$173.23 +1.43% 493,935
26-10-21 US$170.78 -0.49% 452,862
26-10-20 US$171.62 +0.70% 336,335
26-10-19 US$170.42 -0.18% 363,498
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
MarketScreener Ratings - Balchem Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
177.00USD
Average target price
209.25USD
Spread / Average Target
+18.22%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Balchem Corporation
  1. Stock Market
  2. Stocks
  3. BCPC Stock